Xr Securities LLC Sellas Life Sciences Group, Inc. Transaction History
Xr Securities LLC
- $0
- Q1 2025
A detailed history of Xr Securities LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Xr Securities LLC holds 13,100 shares of SLS stock, worth $20,436. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,100Holding current value
$20,436% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
52Shares Held
14.5MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$11.8 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$4.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.28 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$671,3740.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $32.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...